Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis

ABSTRACTThis study aims to conduct a bibliometric analysis, employing visualization tools to examine literature pertaining to tumor immune evasion related to anti-CTLA-4 and anti-PD-1/PD-L1 therapy from 1999 to 2022. A special emphasis is placed on the interplay between tumor microenvironment, signa...

Full description

Bibliographic Details
Main Authors: Yi Huang, Zhijian Chen, Gang Shen, Shuogui Fang, Junjiong Zheng, Zepai Chi, Yuanfeng Zhang, Yitong Zou, Qinghua Gan, Chengxiao Liao, Yuhui Yao, Jianqiu Kong, Xinxiang Fan
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2318815
_version_ 1797291471771009024
author Yi Huang
Zhijian Chen
Gang Shen
Shuogui Fang
Junjiong Zheng
Zepai Chi
Yuanfeng Zhang
Yitong Zou
Qinghua Gan
Chengxiao Liao
Yuhui Yao
Jianqiu Kong
Xinxiang Fan
author_facet Yi Huang
Zhijian Chen
Gang Shen
Shuogui Fang
Junjiong Zheng
Zepai Chi
Yuanfeng Zhang
Yitong Zou
Qinghua Gan
Chengxiao Liao
Yuhui Yao
Jianqiu Kong
Xinxiang Fan
author_sort Yi Huang
collection DOAJ
description ABSTRACTThis study aims to conduct a bibliometric analysis, employing visualization tools to examine literature pertaining to tumor immune evasion related to anti-CTLA-4 and anti-PD-1/PD-L1 therapy from 1999 to 2022. A special emphasis is placed on the interplay between tumor microenvironment, signaling pathways, immune cells and immune evasion, with data sourced from the Web of Science core collection (WoSCC). Advanced tools, including VOSviewer, Citespace, and Scimago Graphica, were utilized to analyze various parameters, such as co-authorship/co-citation patterns, regional contributions, journal preferences, keyword co-occurrences, and significant citation bursts. Out of 4778 publications reviewed, there was a marked increase in research focusing on immune evasion, with bladder cancer being notably prominent. Geographically, China, the USA, and Japan were the leading contributors. Prestigious institutions like MD Anderson Cancer Center, Harvard Medical School, Fudan University, and Sun Yat Sen University emerged as major players. Renowned journals in this domain included Frontiers in Immunology, Cancers, and Frontiers in Oncology. Ehen LP and Wang W were identified as prolific authors on this topic, while Topalian SL stood out as one of the most cited. Research current situation is notably pivoting toward challenges like immunotherapy resistance and the intricate signaling pathways driving drug resistance. This bibliometric study seeks to provide a comprehensive overview of past and current research trends, emphasizing the potential role of tumor microenvironment, signaling pathways and immune cells in the context of immune checkpoint inhibitors (ICIs) and tumor immune evasion.
first_indexed 2024-03-07T19:37:21Z
format Article
id doaj.art-21c9f8870bdf41369ec5529eb545656b
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-07T19:37:21Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-21c9f8870bdf41369ec5529eb545656b2024-02-29T07:58:00ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2318815Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysisYi Huang0Zhijian Chen1Gang Shen2Shuogui Fang3Junjiong Zheng4Zepai Chi5Yuanfeng Zhang6Yitong Zou7Qinghua Gan8Chengxiao Liao9Yuhui Yao10Jianqiu Kong11Xinxiang Fan12Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaDepartment of Urology, DUSHU Lake Hospital Affiliated to Soochow University, Suzhou, ChinaDepartment of Radiotherapy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, P. R. ChinaDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaDepartment of urology, Shantou Central Hospital, Shantou, ChinaDepartment of urology, Shantou Central Hospital, Shantou, ChinaDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaDepartment of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, P. R. ChinaABSTRACTThis study aims to conduct a bibliometric analysis, employing visualization tools to examine literature pertaining to tumor immune evasion related to anti-CTLA-4 and anti-PD-1/PD-L1 therapy from 1999 to 2022. A special emphasis is placed on the interplay between tumor microenvironment, signaling pathways, immune cells and immune evasion, with data sourced from the Web of Science core collection (WoSCC). Advanced tools, including VOSviewer, Citespace, and Scimago Graphica, were utilized to analyze various parameters, such as co-authorship/co-citation patterns, regional contributions, journal preferences, keyword co-occurrences, and significant citation bursts. Out of 4778 publications reviewed, there was a marked increase in research focusing on immune evasion, with bladder cancer being notably prominent. Geographically, China, the USA, and Japan were the leading contributors. Prestigious institutions like MD Anderson Cancer Center, Harvard Medical School, Fudan University, and Sun Yat Sen University emerged as major players. Renowned journals in this domain included Frontiers in Immunology, Cancers, and Frontiers in Oncology. Ehen LP and Wang W were identified as prolific authors on this topic, while Topalian SL stood out as one of the most cited. Research current situation is notably pivoting toward challenges like immunotherapy resistance and the intricate signaling pathways driving drug resistance. This bibliometric study seeks to provide a comprehensive overview of past and current research trends, emphasizing the potential role of tumor microenvironment, signaling pathways and immune cells in the context of immune checkpoint inhibitors (ICIs) and tumor immune evasion.https://www.tandfonline.com/doi/10.1080/21645515.2024.2318815Immune checkpoint inhibitors (ICIs)PD-1/PD-L1CLTA-4immune evasionbibliometrics
spellingShingle Yi Huang
Zhijian Chen
Gang Shen
Shuogui Fang
Junjiong Zheng
Zepai Chi
Yuanfeng Zhang
Yitong Zou
Qinghua Gan
Chengxiao Liao
Yuhui Yao
Jianqiu Kong
Xinxiang Fan
Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis
Human Vaccines & Immunotherapeutics
Immune checkpoint inhibitors (ICIs)
PD-1/PD-L1
CLTA-4
immune evasion
bibliometrics
title Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis
title_full Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis
title_fullStr Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis
title_full_unstemmed Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis
title_short Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis
title_sort immune regulation and the tumor microenvironment in anti pd 1 pdl 1 and anti ctla 4 therapies for cancer immune evasion a bibliometric analysis
topic Immune checkpoint inhibitors (ICIs)
PD-1/PD-L1
CLTA-4
immune evasion
bibliometrics
url https://www.tandfonline.com/doi/10.1080/21645515.2024.2318815
work_keys_str_mv AT yihuang immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT zhijianchen immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT gangshen immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT shuoguifang immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT junjiongzheng immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT zepaichi immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT yuanfengzhang immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT yitongzou immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT qinghuagan immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT chengxiaoliao immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT yuhuiyao immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT jianqiukong immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis
AT xinxiangfan immuneregulationandthetumormicroenvironmentinantipd1pdl1andantictla4therapiesforcancerimmuneevasionabibliometricanalysis